(IN BRIEF) CapMan Buyout has sold Pharmia Holding Oy, the leading Nordic contract manufacturer of dietary supplements and medical devices, to Labomar, an Italy-based European group owned by Charterhouse Capital Partners. Since CapMan’s investment in 2021, Pharmia has grown into a €20 million turnover company with 85 employees, driven by a strategic focus on medical devices, probiotics, and strengthened R&D capabilities. (PRESS RELEASE) HELSINKI, 2-Oct-2025 — /EuropaWire/ — CapMan Buyout has completed the sale of Pharmia Holding Oy, a Finnish contract manufacturer specializing in dietary supplements and medical devices, to Labomar, a European leader in food supplements, medical devices, and functional cosmetics. Joining the Labomar family is an exciting step that strengthens our ability to develop and deliver high-quality dietary supplements and medical devices. About PharmiaPharmia is Finland’s leading contract manufacturer specialised in the development and manufacture of food supplements and medical devices (CE-marked products).